Chia Tai Enterprises International Limited (3839.HK)
HKD 1.64
(0.0%)
HKD 1.64
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 2.55 Million USD | 159.94% |
| 2022 | -4.25 Million USD | -115.95% |
| 2021 | 26.69 Million USD | 64.23% |
| 2020 | 16.25 Million USD | 2.88% |
| 2019 | 15.8 Million USD | -25.34% |
| 2018 | 21.16 Million USD | 29.47% |
| 2017 | 16.34 Million USD | 102.87% |
| 2016 | 8.05 Million USD | -1.52% |
| 2015 | 8.18 Million USD | -57.89% |
| 2014 | 19.43 Million USD | -30.08% |
| 2013 | 27.79 Million USD | 56.88% |
| 2012 | 17.71 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 989 Thousand USD | 144.2% |
| 2024 Q2 | 974 Thousand USD | -1.52% |
| 2023 Q2 | 280 Thousand USD | -83.97% |
| 2023 Q4 | 405 Thousand USD | 234.71% |
| 2023 FY | 2.55 Million USD | 159.94% |
| 2023 Q3 | 121 Thousand USD | -56.79% |
| 2023 Q1 | 1.74 Million USD | 676.44% |
| 2022 FY | -4.25 Million USD | -115.95% |
| 2022 Q3 | -1.91 Million USD | 33.77% |
| 2022 Q4 | 225 Thousand USD | 111.73% |
| 2022 Q1 | -2.08 Million USD | -199.33% |
| 2022 Q2 | -2.89 Million USD | -38.7% |
| 2021 Q1 | 5.25 Million USD | 132.27% |
| 2021 FY | 26.69 Million USD | 64.23% |
| 2021 Q4 | 2.1 Million USD | -80.42% |
| 2021 Q3 | 10.73 Million USD | 630.48% |
| 2021 Q2 | 1.47 Million USD | -72.02% |
| 2020 Q2 | 8.36 Million USD | 159.81% |
| 2020 Q4 | 2.26 Million USD | -6.02% |
| 2020 Q3 | 2.4 Million USD | -71.23% |
| 2020 FY | 16.25 Million USD | 2.88% |
| 2020 Q1 | 3.22 Million USD | 33.78% |
| 2019 Q2 | 5.63 Million USD | -0.46% |
| 2019 Q1 | 5.66 Million USD | 144.62% |
| 2019 FY | 15.8 Million USD | -25.34% |
| 2019 Q4 | 2.4 Million USD | 15.0% |
| 2019 Q3 | 2.09 Million USD | -62.87% |
| 2018 Q4 | 2.31 Million USD | -50.06% |
| 2018 Q2 | 5.74 Million USD | -32.2% |
| 2018 Q1 | 8.47 Million USD | 48.7% |
| 2018 FY | 21.16 Million USD | 29.47% |
| 2018 Q3 | 4.63 Million USD | -19.28% |
| 2017 Q4 | 5.69 Million USD | 35.78% |
| 2017 Q2 | 3.22 Million USD | -0.19% |
| 2017 Q1 | 3.23 Million USD | 129.15% |
| 2017 FY | 16.34 Million USD | 102.87% |
| 2017 Q3 | 4.19 Million USD | 30.08% |
| 2016 Q3 | 2.17 Million USD | -2.03% |
| 2016 Q2 | 2.22 Million USD | -1.2% |
| 2016 Q1 | 2.24 Million USD | -18.9% |
| 2016 Q4 | 1.41 Million USD | -35.23% |
| 2016 FY | 8.05 Million USD | -1.52% |
| 2015 FY | 8.18 Million USD | -57.89% |
| 2015 Q4 | 2.77 Million USD | 9.35% |
| 2015 Q3 | 2.53 Million USD | 31.2% |
| 2015 Q2 | 1.93 Million USD | -23.6% |
| 2015 Q1 | 2.53 Million USD | -56.59% |
| 2014 Q4 | 5.82 Million USD | 166.61% |
| 2014 Q3 | 2.18 Million USD | -61.7% |
| 2014 Q2 | 5.7 Million USD | 0.0% |
| 2014 Q1 | 5.7 Million USD | 0.0% |
| 2014 FY | 19.43 Million USD | -30.08% |
| 2013 FY | 27.79 Million USD | 56.88% |
| 2012 FY | 17.71 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 105.03 Million HKD | 97.569% |
| Grand Pharmaceutical Group Limited | 1.87 Billion HKD | 99.864% |
| Extrawell Pharmaceutical Holdings Limited | -162.94 Million HKD | 101.567% |
| Wai Yuen Tong Medicine Holdings Limited | -15.35 Million HKD | 116.625% |
| Qianhai Health Holdings Limited | -52.7 Million HKD | 104.844% |
| Lee's Pharmaceutical Holdings Limited | 16.69 Million HKD | 84.711% |
| Essex Bio-Technology Limited | 275.25 Million HKD | 99.073% |
| Tongfang Kontafarma Holdings Limited | -28.84 Million HKD | 108.851% |
| PuraPharm Corporation Limited | -106.08 Million HKD | 102.407% |
| SSY Group Limited | 1.31 Billion HKD | 99.806% |
| JBM (Healthcare) Limited | 130.46 Million HKD | 98.043% |
| Jacobson Pharma Corporation Limited | 266.96 Million HKD | 99.044% |
| China Resources Pharmaceutical Group Limited | 3.85 Billion HKD | 99.934% |